
Alexandra Bercow, MD
Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery
Present Title & Affiliation
Primary Appointment
Assistant Professor, Department of Gynecologic Oncology and Reproductive Medicine, Division of Surgery, The University of Texas MD Anderson Cancer Center, Houston, Texas
Education & Training
Degree-Granting Education
2017 | Columbia University, College of Physicians & Surgeons, New York, NY, US, Doctor of Medicine |
2011 | Yale University, New Haven, CT, US, Political Science; Concentration: Health Politics and Policy, Bachelor of Arts |
Postgraduate Training
2021-2024 | Fellow, Massachusetts General Hospital, Boston, MA |
2017-2021 | Resident, Brigham and Women's Hospital and Massachusetts General Hospital, Boston, MA |
Experience & Service
Academic Appointments
Research and Clinical Fellow, Department of Vincent Department of Obstetrics and Gynecology, Massachusetts General Hospital, Boston, MA, 2021 - 2024
Administrative Chief Resident, Boston MA, 2020 - 2021
Institutional Committee Activities
Member, Executive Committee on Teaching and Education, 2023 - 2024
Member, Graduate Education Committee, 2021 - 2023
Member, Education Committee, 2020 - 2024
Member, Surgical Curriculum Committee, 2019 - 2020
Ob/Gyn Representative, Brigham and Women's Housestaff Council, 2018 - 2020
Member, Dean's Resident and Faculty Communications Taskforce, 2016 - 2017
Member, Junior Admissions Committee, 2015 - 2017
Member, Dean's Advisory Committee, 2013 - 2017
Honors & Awards
Recognition for Outstanding Presentation, Department of Neurology | |
Alpha Omega Alpha, Columbia University, College of Physicians & Surgeons | |
Glasgow-Rubin Certificate of Commendation for Academic Achievement, American Medical Women's Association | |
Dean of Students Award, Columbia University, College of Physicians & Surgeons | |
Department Award for Best Abstract on Clinical Research Day, Massachusetts General Hospital | |
Harvard Medical School Excellence in Teaching Award, Harvard Medical School | |
Harvard Medical School Excellence in Teaching Award, Harvard Medical School |
Selected Publications
Peer-Reviewed Articles
- Vardar B, Bercow A, Melamed A, Pierce T. Nonpuerperal Uterine Inversion. Radiol Imaging Cancer 6(6):e240162, 2024. PMID: 39452889.
- Bercow A, Stewart T, Bregar AJ, Gockley A, Mazina V, Rauh-Hain JA, Melamed A. Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer. JAMA Netw Open 7(10):e2439893, 2024. PMID: 39412808.
- Mazina V, Devins K, Philp L, Bercow, AS, James K, Bregar A, Sisodia RC, Oliva E, Del Carmen M. Patterns of spread and genetic alterations of primary endometrioid carcinomas of the ovary. Int J Gynecol Cancer 33(9):1434-1439, 2023. PMID: 37567599.
- Silberman JN, Bercow AS, Gockley AA, Eisenhauer EL, Sisodia R, Randall T, Del Carmen MG, Goodman A, Castro CM, Melamed A, Bregar AJ. Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States. Gynecol Oncol 175:60-65, 2023. PMID: 37327540.
- Bercow AS, Rauh-Hain JA, Melamed A, Mazina V, Growdon WB, Del Carmen MG, Goodman A, Bouberhan S, Randall T, Sisodia R, Bregar A, Eisenhauer EL, Minami C, Molina G. Association of hospital-level factors with utilization of sentinel lymph node biopsy in patients with early-stage vulvar cancer. Gynecol Oncol 169(None):47-54, 2023. PMID: 36508758.
- Bercow AS, Rauh-Hain JA, Melamed A, Mazina V, Growdon WB, Del Carmen MG, Goodman A, Bouberhan S, Bregar A, Eisenhauer EL, Molina G, Minami C. Guideline-Discordant Care in Early-Stage Vulvar Cancer. Obstet Gynecol 140(6):1031-1041, 2022. PMID: 36357957.
- Li S, Bercow AS, Falzone M, Kalyanaraman R, Worley MJ, Feltmate CM, Pelletier A, Elias KM. Risk of venous thromboembolism for ovarian cancer patients during first-line therapy after implementation of an Enhanced Recovery After Surgery (ERAS) protocol. Gynecol Oncol 162(2):353-359, 2021. PMID: 34092412.
- Bercow A, Nitecki R, Brady PC, Rauh-Hain JA. Outcomes after Fertility-sparing Surgery for Women with Ovarian Cancer: A Systematic Review of the Literature. J Minim Invasive Gynecol 28(3):527-536.e1, 2021. PMID: 32861046.
- Harvey RA, Elias KM, Lim A, Bercow A, Short D, Horowitz NS, Berkowitz RS, Agarwal R, Seckl MJ. Uterine artery pulsatility index and serum BMP-9 predict resistance to methotrexate therapy in gestational trophoblastic neoplasia: A cohort study. Curr Probl Cancer 45(1):100622, 2021. PMID: 32800689.
- Bercow AS, Nitecki R, Haber H, Gockley AA, Hinchcliff E, James K, Melamed A, Diver E, Kamdar MM, Feldman S, Growdon WB. Palliative care referral patterns and measures of aggressive care at the end of life in patients with cervical cancer. Int J Gynecol Cancer 31(1):66-72, 2021. PMID: 33046575.
- Nitecki R, Bercow AS, Gockley AA, Lee H, Penson RT, Growdon WB. Clinical trial participation and aggressive care at the end of life in patients with ovarian cancer. Int J Gynecol Cancer 30(2):201-206, 2020. PMID: 31911533.
- Melamed A, Bercow AS, Bunnell K, Rauh-Hain JA, Wright JD, Rice LW, Del Carmen MG. Age-Associated Risk of 90-Day Postoperative Mortality After Cytoreductive Surgery for Advanced Ovarian Cancer. JAMA Surg 154(7):669-671, 2019. PMID: 31066875.
- Bercow AS, Chen L, Chatterjee S, Tergas AI, Hou JY, Burke WM, Ananth CV, Neugut AI, Hershman DL, Wright JD. Cost of Care for the Initial Management of Ovarian Cancer. Obstet Gynecol 130(6):1269-1275, 2017. PMID: 29112648.
- D'Amico RS, Banu MA, Petridis P, Bercow AS, Malone H, Praver M, Wang TJC, Isaacson SR, Sisti MB. Efficacy and outcomes of facial nerve-sparing treatment approach to cerebellopontine angle meningiomas. J Neurosurg 127(6):1231-1241, 2017. PMID: 28186449.
Other Articles
- Bercow A, Del Carmen MG, Rauh-Hain JA, Melamed A Role of Minimally Invasive Techniques in the Management of Early-Stage Carcinoma of the Uterine Cervix. J Clin Oncol 42(23):2731-2735, 2024. PMID: 38917386.
- Bercow AS, Eisenhauer EL Screening and surgical prophylaxis for hereditary cancer syndromes with high risk of endometrial and ovarian cancer. J Surg Oncol 120(5):864-872, 2019. PMID: 31355450.
Selected Presentations & Talks
Local Presentations
- 2022. NCCN Guideline-Discordant Care in Early-Stage Vulvar Cancer: A National Cancer Database Study. Poster. Massachusetts General Hospital’s Celebration of Science Symposium. Boston, Massachusetts, US.
- 2019. Clinical Trial Participation and Measures of Aggressive Care at the End of Life in Patients with Ovarian Cancer. Poster. Massachusetts General Hospital Clinical Research Day. Boston, Massachusetts, US.
- 2010. Increased Reprogramming Efficiency Through Fluorescence Activated Cell Sorting. Poster. New York Stem Cell Foundation Conference. New York, New York, US.
Regional Presentations
- 2024. Chemotherapy followed by interval cytoreductive surgery has become the most prevalent approach in the upfront treatment of patients with advanced-stage epithelial ovarian cancer in the US. Conference. New England Association of Gynecologic Oncologists Annual Conference. Cape Cod, Massachusetts, US.
- 2023. Concurrent laparoscopic hysterectomy and bariatric surgery for early-stage endometrial cancer and endometrial intraepithelial neoplasia: early results and lessons learned from an interdisciplinary prospective feasibility trial. Conference. New England Association of Gynecologic Oncologists Annual Conference. Portland, Maine, US.
- 2023. Association between Utilization of Sentinel Lymph Node Biopsy in Vulvar Cancer and Hospital Volume of Breast Cancer and Melanoma. Conference. New England Association of Gynecologic Oncologists Annual Conference. Portland, Maine, US.
- 2022. Sentinel Lymph Node Biopsy Utilization in Early-Stage Vulvar Cancer: A National Cancer Database Study. Conference. New England Association of Gynecologic Oncologists Annual Conference. Newport, Rhode Island, US.
- 2022. NCCN Guideline-Discordant Care in Early-Stage Vulvar Cancer: A National Cancer Database Study. Conference. New England Association of Gynecologic Oncologists Annual Conference. Newport, Rhode Island, US.
- 2019. Clinical Trial Participation, Overall Survival, and Measures of Aggressive Care at the End of Life in Patients with Ovarian Cancer. Conference. New England Association of Gynecologic Oncologists Annual Conference. Bretton Woods, New Hampshire, US.
- 2018. Concurrent Hysterectomy and Weight Loss Surgery in obese patients with Endometrial Cancer. Conference. New England Association of Gynecologic Oncologists Annual Conference. Ogunquit, Maine, US.
National Presentations
- 2024. Utilization of Primary Cytoreductive Surgery for Advanced-Stage Ovarian Cancer. Poster. Society of Gynecologic Oncology Annual Meeting. San Diego, California, US.
- 2023. Trends in the use of neoadjuvant chemotherapy for low-grade serous ovarian cancer in the United States. Poster. ASCO Annual Meeting. Chicago, Illinois, US.
- 2023. Association between utilization of sentinel lymph node biopsy in vulvar cancer and hospital volume of melanoma and breast cancer. Poster. SGO Annual Meeting. Tampa, Florida, US.
- 2022. Association between Utilization of Sentinel Lymph Node Biopsy in Vulvar Cancer and Hospital Volume of Breast Cancer and Melanoma. Conference. Gynecologic Oncology Fellows Forum. Denver, Colorado, US.
- 2022. NCCN Guideline-Discordant Care in Early-Stage Vulvar Cancer: A National Cancer Database Study. Poster. Academy Health Annual Meeting. Washington D.C, US.
- 2022. Utilization of Sentinel Lymph Node Biopsy in Early-Stage Vulvar Cancer: A National Cancer Database Study. Poster. ASCO Annual Meeting. Chicago, Illinois, US.
- 2020. Palliative Care is associated with less aggressive care at the end of life for cervical cancer patients. Conference. Society of Gynecologic Oncology Winter Meeting. Aspen, Colorado, US.
- 2019. Participation in Ovarian Cancer Clinical Trials is Associated with Improved Overall Survival. Poster. The Society of Gynecologic Oncology (SGO) 50th Annual Meeting on Women’s Cancer. Honolulu, Hawaii, US.
- 2019. Age-Related Risk of Postoperative Mortality after Cytoreductive Surgery for Advanced Ovarian Cancer. Poster. The Society of Gynecologic Oncology (SGO) 50th Annual Meeting on Women’s Cancer. Honolulu, Hawaii, US.
- 2019. Clinical Trial Participation and Measures of Aggressive Care at the End of Life in Patients with Ovarian Cancer. Poster. The Society of Gynecologic Oncology (SGO) Annual Winter Meeting. Lake Tahoe, California, US.
International Presentations
- 2020. Palliative Care is Associated with Less Aggressive Care at the End of Life for Patients with Cervical Cancer. Poster. International Papillomavirus Conference. Barcelona, ES.
Formal Peers
- 2021. The Pelvic Exam. Boston, Massachusetts, US.
- 2021. Introduction to Gynecologic Oncology. Boston, Massachusetts, US.
Patient Reviews
CV information above last modified January 30, 2025